GL1X · GenesisL1 explorer

MolNFT v1 · #102852 · protein

Human solac complexed with (4-amino-furazan-3-yl)-(3-methoxy-phenyl)- methanone

4OYM · Adenylate cyclase type 10: “Human solac complexed with (4-amino-furazan-3-yl)-(3-methoxy-phenyl)- methanone”. X-ray diffraction, 2 ligands (ACE, 1ZC), 5 pockets (best druggability 0.78). MolNFT v1 #102852 on GenesisL1: 3D structure…

PDB
4OYM
Type
protein
Length
468 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Adenylate cyclase type 10
EC
4.6.1.1
UniProt
Q96PN6
Ligands
ACE, 1ZC
Pockets
5 · best druggability 0.78

Structure

x-ray diffraction · 1 distinct chain · 38% helix, 28% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAdenylate cyclase type 10 (EC 4.6.1.1)protein46838% helix, 28% strandQ96PN6

Ligands and binding sites

  • ACE · Acetyl group · ligand · chains A
  • 1ZC · (4-azanyl-1,2,5-oxadiazol-3-yl)-(3-methoxyphenyl)methanone · ligand · chains A
  • GOL · Glycerol · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12070.780.9231GOL
24440.730.83561ZC
31860.650.8529empty
41400.420.7524empty
5610.300.7518GOL

Modifications

Observed in the structure: 1 covalent, 1 modified (covalent ligand, artifact).

Compared structures

  • 4OYM · Human solAC Complexed with (4-Amino-furazan-3-yl)-(3-methoxy-phenyl)-metha · the same entry in another collection · chain A against A, TM-score 1.00
  • Q96PN6 · AlphaFold monomer V2.0 prediction for adenylate cyclase type 10 (Q96PN6) · a predicted model of the same protein · chain A against A, TM-score 0.95

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.